Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372296
Max Phase: Preclinical
Molecular Formula: C51H75N13O11S2
Molecular Weight: 1110.37
Molecule Type: Unknown
Associated Items:
ID: ALA2372296
Max Phase: Preclinical
Molecular Formula: C51H75N13O11S2
Molecular Weight: 1110.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC1(CC)CC(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)CSS1
Standard InChI: InChI=1S/C51H75N13O11S2/c1-6-51(7-2)26-41(67)58-34(24-31-17-19-32(75-5)20-18-31)44(69)60-35(23-30-13-9-8-10-14-30)46(71)63-42(29(3)4)48(73)61-36(25-39(52)65)45(70)62-37(28-76-77-51)49(74)64-22-12-16-38(64)47(72)59-33(15-11-21-56-50(54)55)43(68)57-27-40(53)66/h8-10,13-14,17-20,29,33-38,42H,6-7,11-12,15-16,21-28H2,1-5H3,(H2,52,65)(H2,53,66)(H,57,68)(H,58,67)(H,59,72)(H,60,69)(H,61,73)(H,62,70)(H,63,71)(H4,54,55,56)/t33-,34-,35-,36-,37-,38-,42-/m0/s1
Standard InChI Key: HULLMWIMYUELPG-GPHUSYHNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1110.37 | Molecular Weight (Monoisotopic): 1109.5150 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):